Botox Faces Competition Soon

Submitted by Meg Wilson on February 5, 2008 - 19:56.

Allergan is the company that makes Botox and they are by far the largest company in Orange County, Los Angeles based on Wall Street rankings. The company is worth about $20 billion based on their current market cap. Botox accounted for about 40% of their 2007 revenues.

But a new competing product to Botox, Reloxin, will probably be launched before the end of this year. It's a wrinkle remover that's chemically similar to Botox but developed by their competitors, Medicis Pharmaceutical Corp.

See more about the competitive situation coming up for Allergan here.


Story Source | add new comment
( categories: Botox Injections )
I'm all for competition
Submitted by Guest (not verified) on February 11, 2008 - 11:48.

Allergan does have a fight on their hands, if not this year than very soon. It's inevitable, with the huge success of BOTOX Cosmetic in recent years. I work with a medispa that offers BOTOX on Long Island and the treatment couldn't be more popular. The inevitable advertising that follows launch of a competitor will only place this type of medspa treatment even more prominently in the minds of people who are interested in wrinkle reduction. Competition may not be good for Allergan, but it will be great for consumers of all ages who want non-surgical wrinkle correction.

reply